Our guest on this ALCSI podcast is Dr. Lecia Sequist. Dr. Sequist is a medial oncologist at Massachusetts General Hospital, where she serves as the program director of the Cancer Early Detection & Diagnostic Clinic. Dr. Sequist received her undergraduate degree from Cornell University before attending Harvard Medical School, subsequently going to study internal medical at Brigham and Women's Hospital and hematology & oncology at the Dana-Farber Cancer Institute. In 2005 she joined the faculty at Massachusetts General Hospital Cancer Center and since joining, has had an active and fruitful career centered around caring for lung cancer patients, as well as conducting both clinical and translational research. Dr. Sequist has held grants from the NIH, DOD, and many other private foundations, and her research has been highly influential in developing targeted therapeutics and novel detection techniques.

Your podcast hosts are Pranav Mandyam, Jacob Rashap, and Sam Schwartz. Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, thousands of lives could be saved this year alone. However, less than 5% of high-risk Americans are currently getting screened. Visit our website at ⁠https://www.alcsi.org/⁠ for free educational resources and webinars on lung cancer and lung cancer screening. Email: info@alcsi.org Twitter: @AmLungCSI Instagram: @amlungcsi